Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation

European Journal of Endocrinology

Volumn 143, Issue 1, 2000, Pages 71-76

  Enberg, B ^a   Luthman, H ^a   Segnestam, K ^b   Ritzen E M ^a   Sundstrom M ^c   Norstedt, Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Mälarsjukhuset Hospital   (Sweden)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; GENE MUTATION; GROWTH RETARDATION; HUMAN; LARON SYNDROME; MALE; MISSENSE MUTATION; MOLECULAR MODEL; PRIORITY JOURNAL;

EID: 0033911325     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430071     Document Type: Article

References (19)

1. Laron Z, Pertzelan A & Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Israeli Journal of Medicine 1966 2 152-155.
2. Godowski PJ, Leung DW & Meacham LR. Characterization of the growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. PNAS 1989 86 8083-8087.
3. Leung DW, Spencer SA & Cachianes G. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987 330 537-543.
4. Kelly PA, Djiane J, Postel-Vinay MC & Edery M. The prolactin/ growth hormone receptor family. Endocrine Reviews 1991 12 235-251.
5. Bazan FJ. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoetin and IL-6 receptors, and the p/5 IL-2 receptor β-chain. Biochemical and Biophysical Research Communications 1989 164 788-795.
6. Baumann G. Growth hormone binding proteins. Proceedings of the Society for Experimental Biology and Medicine 1993 202 392-400.
7. Laron Z, Klinger B, Erster B & Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinologica 1989 121 603-608.
8. Clayton PE, Freeth JS, Whatmore AJ, Ayling RM, Norman MR & Silva CM. Signal transduction defects in growth hormone insensitivity. Acta Paediatrica Scandinavica 1999 88 174-178.
9. Boguszewski CL, Carlsson B & Carlsson LM. Mechanisms of growth failure in non-growth-hormone deficient children of short stature. Hormone Research 1997 48 19-22.
10. Wood TJ, Haldosén L-A, Sliva D, Sundström M & Norstedt G. Stimulation of kinase cascades by growth hormone: a paradigm for cytokine signalling. Progress in Nucleic Acid Research and Molecular Biology 1997 57 73-94.
11. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A & Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. Journal of Clinical Endocrinology and Metabolism 1971 33 332-342.
12. Daughaday WH & Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Reviews 1989 10 68-91.
13. Rosenfeld RG, Rosenbloom AL & Guevaraaguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews 1994 3 569-390.
14. Amselem S, Sobrier ML, Dastot F, Duquesnoy P, Duriez B & Gossens M. Molecular basis of inherited growth hormone resistance in childhood. Baillieres Clinical Endocrinology and Metabolism 1996 10 353-369.
15. Ranke MB. Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). Baillieres Clinical Endocrinology and Metabolism 1996 10 401-410.
16. Sundström M, Milligan D, Rödin J, Giebel L, Lundquist T & Norstedt G. The crystal structure of an antagonist mutant of human growth hormone in complex with its receptor at 2.9 Å resolution - a comparision with the native hormone complex at 2.5 Å. Journal of Biological Chemistry 1996 271 32 197-201.
17. Kastrup KW, Andersen H & Hanssen AF. Increased immunoreactive plasma and urinary growth hormone in growth retardation with defective generation of somatomedin a (Laron's Syndrome). Acta Paediatrica Scandinavica 1975 64 613-618.
18. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG & Fielder PJ. Is there heterozygote expression of growth hormone receptor deficiency? Acta Paediatrica Scandinavica 1994 83 125-127.
19. Kou K, Lajara R & Rotwein P. Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. Journal of Clinical Endocrinology and Metabolism 1993 1 54-59.